AZoLifeSciences on MSN
Proteomics approaches to overcome undruggable targets in disease
This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...
New findings from Karolinska Institutet reveal how the gene HNRNPU coordinates several fundamental molecular processes during ...
Researchers uncover a redox-regulated mechanism that determines whether bone fractures heal or progress to nonunion ...
A novel study uncovers how a subtle chemical tweak transforms the naturally occurring phytotoxin into a powerful molecular ...
Membrane proteins are vital for cellular signaling, transport, and communication, making them attractive drug targets despite their challenging properties. Advances in mass spectrometry have enabled ...
New findings from Karolinska Institutet reveal how the gene HNRNPU coordinates several fundamental molecular processes during ...
Producing high levels of valuable medicinal compounds in plants has long been limited by the difficulty of precisely ...
Researchers uncover a redox-regulated mechanism that determines whether bone fractures heal or progress to non-union.
Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, ...
Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.
Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results